Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

TCRX US Equity

TScan Therapeutics, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1783328 · FY ends Dec 31
$0.75
-0.07 (-9.06%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 2 13G
DateEventWhat happened / filerSource
2026-08-188-K 1.02Termination of a material definitive agreementsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Lynx1 Capital Management LPsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BIOTECHNOLOGY VALUE FUND L Psec.gov ↗
2026-08-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-08-12

Every row is a filed document, checked against its EDGAR index.